VYCO logo

Vycor Medical, Inc. Stock Price

OTCPK:VYCO Community·US$2.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VYCO Share Price Performance

US$0.063
-0.07 (-51.19%)
US$0.063
-0.07 (-51.19%)
Price US$0.063

VYCO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with slight risk.

4 Risks
2 Rewards

Vycor Medical, Inc. Key Details

US$1.9m

Revenue

US$307.8k

Cost of Revenue

US$1.6m

Gross Profit

US$1.9m

Other Expenses

-US$336.0k

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.01
83.67%
-17.82%
-22.3%
View Full Analysis

About VYCO

Founded
2005
Employees
7
CEO
Peter Zachariou
WebsiteView website
www.vycormedical.com

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Recent VYCO News & Updates

Recent updates

No updates